CLASS II ONGOING Device recall · Reported 18 Feb 2026 · FDA Enforcement Report

Brevera Breast Biopsy System Disposable Needle recalled by Hologic

Hologic is recalling Brevera Breast Biopsy System Disposable Needle, distributed nationwide in the US. The recall was initiated on 15 Dec 2025 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesModel No - BREVDISP09; UDI - 1540045512863; All Lots within expiry.
Quantity recalled681,870 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1314-2026
FDA event ID
98172
Recalling firm
Hologic, Marlborough, MA
Classification
Class II
Status
Ongoing
Recall initiated
15 Dec 2025
FDA classified
6 Feb 2026
Reported
18 Feb 2026
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Particulate Matter

Timeline

15 Dec 2025Recall initiated by company
6 Feb 2026Classified by FDA+53 days
18 Feb 2026Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Presence of particulates in affected devices that can be deposited into breast tissue during use.

Product as listed by the FDA

Brevera Breast Biopsy System Disposable 9 Gauge Needle. Biopsy Instrument.

Where it was distributed

US Nationwide distribution.

Nationwide

Questions about this recall

Why was it recalled?

Presence of particulates in affected devices that can be deposited into breast tissue during use.

Which lots are affected?

Model No - BREVDISP09; UDI - 1540045512863; All Lots within expiry.

Where was it sold?

US Nationwide distribution.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Hologic

All 48
ReportedClassRecallCompanyReasonWhere
DeviceCLASS II3dimensions Mammography System recalled by HologicHologicOtherNationwide
DeviceCLASS IISelenia Dimensions Mammography Systems recalled by HologicHologicOtherNationwide
DeviceCLASS IIGenius" Review Station Display (Barco Monitor) recalled by HologicHologicDevice MalfunctionNationwide
DeviceCLASS IIAptima HPV Assay recalled by HologicHologicPotency & AssayNationwide
DeviceCLASS IIThinPrep¿ CytoLyt¿ Solution recalled by HologicHologicOtherNationwide

Other Syringes & Needles recalls

All 1,066